½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual Meeting


»¶Ó­À´µ½ÉϺ£Í¨Îµ£¡

021-54845833/15800441009

Æ·Öʱ£Ö¤ ¡¤ ͨεÊÔ¼Á

µ±Ç°Î»ÖÃ: Ê×Ò³ > ¿ÆÑвúÆ· > ¿ÆÑп¹Ìå > Ò»¿¹ > Íÿ¹MYL3¶à¿Ë¡¿¹Ìå

²úÆ·ÖÐÐÄ

×îвúÆ·

  • Íÿ¹MYL3¶à¿Ë¡¿¹Ìå

    ¹æ¸ñ£º
    ¼Û¸ñ£º£¤
    • Æ·ÅÆ : ͨεÉúÎï
    • Ŀ¼ºÅ : TW20169
    • Ó¦Óà : ½ö¹©¿ÆÑÐʹÓÃ
    • »õÆÚ : ÏÖ»õ
    • ¹æ¸ñ £º100ul/200ul/25ul
  • ÉÌÆ·ÏêÇé
  • ²Î¿¼ÎÄÏ×
  • ˵Ã÷ÊéÏÂÔØ
  • ÉÌÆ·ÆÀÂÛ0
  • Ïà¹Ø²úÆ·


ÖÐÎÄÃû³Æ£º  Íÿ¹MYL3¶à¿Ë¡¿¹Ìå


Ó¢ÎÄÃû³Æ£º  Anti-MYL3 rabbit polyclonal antibody


±ð       Ãû£º  CMH8; VLC1; MLC1V; MLC1SB


Ïà¹ØÀà±ð£º  Ò»¿¹


´¢      ´æ£º  Àä¶³£¨-20¡æ£©


ËÞ      Ö÷£º  Rabbit


¿¹      Ô­£º  MYL3


·´Ó¦ÖÖÊô£º  Human, Mouse, Rat


±ê  ¼Ç  Î  Unconjugate


¿Ë¡ÀàÐÍ£º  rabbit polyclonal


¼¼Êõ¹æ¸ñ

Background:

MYL3 encodes myosin light chain 3, an alkali light chain also referred to in the literature as both the ventricular isoform and the slow skeletal muscle isoform. Mutations in MYL3 have been identified as a cause of mid-left ventricular chamber type hypertrophic cardiomyopathy.

Applications:

ELISA, WB, IHC

Name of antibody:

MYL3

Immunogen:

Fusion protein of human MYL3

Full name:

myosin, light chain 3, alkali; ventricular, skeletal, slow

Synonyms£º

CMH8; VLC1; MLC1V; MLC1SB

SwissProt:

P08590

ELISA Recommended dilution:

2000-10000

IHC positive control:

Human lung cancer and human liver cancer

IHC Recommend dilution:

50-200

WB Predicted band size:

22 kDa

WB Positive control:

Mouse heart tissue

WB Recommended dilution:

1000-5000







¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿